Clinical Trial Update: FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fecal microbiota transplantation combined with immunotherapy and chemotherapy as first-line treatment for driver-gene negati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• Fecal microbiota transplantation (FMT)
• Immunotherapy (unspecified)

Snippet

Sponsor: Changzhou No.2 People's Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING